Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019

Detalles Bibliográficos
Autores principales: Haston, Julia C., Hwang, Jimee, Tan, Kathrine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871897/
https://www.ncbi.nlm.nih.gov/pubmed/31751320
http://dx.doi.org/10.15585/mmwr.mm6846a4
_version_ 1783472434454724608
author Haston, Julia C.
Hwang, Jimee
Tan, Kathrine R.
author_facet Haston, Julia C.
Hwang, Jimee
Tan, Kathrine R.
author_sort Haston, Julia C.
collection PubMed
description
format Online
Article
Text
id pubmed-6871897
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-68718972019-12-05 Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019 Haston, Julia C. Hwang, Jimee Tan, Kathrine R. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2019-11-22 /pmc/articles/PMC6871897/ /pubmed/31751320 http://dx.doi.org/10.15585/mmwr.mm6846a4 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Haston, Julia C.
Hwang, Jimee
Tan, Kathrine R.
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title_full Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title_fullStr Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title_full_unstemmed Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title_short Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
title_sort guidance for using tafenoquine for prevention and antirelapse therapy for malaria — united states, 2019
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871897/
https://www.ncbi.nlm.nih.gov/pubmed/31751320
http://dx.doi.org/10.15585/mmwr.mm6846a4
work_keys_str_mv AT hastonjuliac guidanceforusingtafenoquineforpreventionandantirelapsetherapyformalariaunitedstates2019
AT hwangjimee guidanceforusingtafenoquineforpreventionandantirelapsetherapyformalariaunitedstates2019
AT tankathriner guidanceforusingtafenoquineforpreventionandantirelapsetherapyformalariaunitedstates2019

Ejemplares similares